The Era of Medical Aesthetics 3.0 Arrives: Gengmei App Launches 'Gengmei AI' to Deliver End-to-End Solutions for Users

VCBeat (WeChat ID: vcbeat) has learned that on August 21, the Gengmei AI Launch Event and the Award Ceremony of the 2019 Young Doctors Competition, hosted by Gengmei APP, a leading professional medical aesthetics platform in China, were grandly held at the Hyatt Regency Beijing Wangjing. Themed “New Trends, New Aesthetics, New Forces,” the event saw Gengmei APP unveil its “Gengmei AI” suite of features, announcing that the medical aesthetics industry is officially transitioning from the 2.0 era of “Internet + Medical Aesthetics” into the 3.0 era ushered in by “5G + AI.”

“Gengmei AI” leverages Gengmei’s vast database of facial images, extensive image data on medical aesthetic and plastic surgery procedures, and the professional aesthetic expertise and experience accumulated through deep engagement in the medical aesthetics industry. Powered by Gengmei’s advanced core AI technologies, it creates the “Gengmei AI Brain.”

This is Gengmei’s upgraded all-scenario AI facial aesthetic perception and analysis tool, following its industry-first launch of a plastic surgery simulator in 2017. Currently, it offers features such as Gengmei AI Intelligent Facial Diagnostic Analysis and Gengmei AI Intelligent Facial Deformation Simulation.

Guests attending the conference included Liu Di, Founder and CEO of Gengmei; Qi Fei, Investment Director at Legend Capital; Huang Yuanpu, Founder of Yiou and EqualOcean; Wang Sijing, Co-Founder and COO of Gengmei; Li Weirui, General Manager of Gengmei; Yang Jingzhi, Joint Investor at Jianli Meishiqin Group and General Manager of Beijing Meishiqin Medical Aesthetics; An Feifei, Deputy General Manager of Beijing Yestar Medical Aesthetic Hospital; Wu Guoping, Dean of Nanjing Medical University Friendship Plastic Surgery Hospital; Wan Lianzhuang, Dean of Hangzhou Yestar Medical Aesthetic Hospital; and Xue Hongyu, Deputy Director of the Department of Plastic Surgery at Peking University Third Hospital.

More than 100 elite representatives from the beauty and aesthetics industry, along with nearly 60 authoritative media outlets, attended the event to witness the launch of Gengmei AI and celebrate the honorary moments for the institutions and doctors awarded in the 2019 Gengmei Young Doctors Competition.

Event Venue

At the conference, Liu Di, founder and CEO of Gengmei APP, delivered the opening remarks. He recounted Gengmei’s six-year development journey, highlighting that aesthetic standards in the medical aesthetics industry are shifting from a single, standardized model to personalized approaches, marking the new era of medical aesthetics as one of customized solutions. To this end, with 36 million users, 8,000 partner institutions, and 20,000 doctors on its platform, and against the backdrop of technological upgrades, Gengmei APP successfully completed the research, development, and launch of Gengmei AI. He also predicted that China’s medical aesthetics industry would enter its “3.0 Era” in 2020.

Mr. Liu Di, Founder and CEO of the Gengmei App

Li Weirui, General Manager of the Gengmei App, provided a detailed overview of the three historical phases of the medical aesthetics industry:

The development of the medical aesthetics industry can be divided into three eras: 1.0, 2.0, and 3.0. Era 1.0 was the nascent stage of medical aesthetics, initially focusing primarily on reconstructive repairs for accidental injuries such as burns and scalds, with a later increase in aesthetic demands.

The “Internet + Medical Aesthetics” model ushered in the era of Medical Aesthetics 2.0. Leveraging the dividends of mobile internet and 4G, medical aesthetics apps represented by Gengmei established a community-plus-e-commerce model, connecting doctors/institutions with consumers.

Now that the 5G era has arrived, officially ushering in the second half of the internet age, public aesthetics are shifting from standardized, one-size-fits-all templates to personalized, individualized preferences, heralding the advent of Medical Aesthetics 3.0.

Gengmei has recently launched features such as AI-powered facial diagnostic analysis and AI-based facial deformation simulation. These tools help users analyze their facial characteristics, assess the proportions of their facial features, and identify suitable plastic surgery templates. Combining entertainment value with practical utility, these features not only assist medical aesthetics clients in intelligently customizing their treatment plans but also serve as a key instrument for Gengmei to attract beauty-conscious users. Looking ahead, Gengmei will leverage 5G and AI technologies to continue developing new functionalities, accelerating the arrival of an era defined by the integration of medical aesthetics, AI, and AR.

Mr. Li Weirui, General Manager of the Gengmei App

Wang Sijing, Co-founder and COO of the Gengmei App, delivered a keynote speech titled “In the New Era of Medical Aesthetics, How Can AI Achieve Precise User Conversion?”

In the past, Gengmei’s recommendation mechanism relied solely on on-platform behavioral data—such as searches, browsing history, and purchase records—to categorize users and generate recommendations. Now, by leveraging Gengmei AI, users receive multi-dimensional analyses of their facial features, including facial proportions and specific characteristics, enabling more precise aesthetic suggestions. For instance, among users with square chins, Gengmei AI recommends botulinum toxin injections for masseter reduction to those with a younger skin age, while proposing dermal filler treatments to those with an older skin age. This is because collagen loss associated with aging can diminish the effectiveness of masseter-reducing injections. Since skin condition and chin shape represent distinct analytical dimensions, cross-dimensional analysis yields more accurate aesthetic solutions. Gengmei AI will continue to expand and refine its coverage of analytical dimensions in the future.

Gengmei aims to leverage AI in collaboration with its operations and business teams to continuously refine its offerings, evolving into a platform that provides comprehensive solutions for users rather than merely serving as a price-comparison tool.

Wang Sijing revealed that after the launch of Gengmei’s AI-powered facial diagnostic analysis feature, an increasing number of users who are beauty-conscious but not necessarily seeking medical aesthetic procedures have joined the Gengmei platform. These users may not have the patience to read through hundreds of personal diaries; they simply want to see what their eyes truly look like. To engage such users, the platform needs to capture their interest with a small amount of high-quality, curated content.

Gengmei assists users who desire aesthetic improvements but lack the patience or ability to conduct in-depth research and navigate complex information, by identifying the most suitable providers for them. When we identify these users as high-net-worth individuals, we recommend the industry’s most senior and top-tier physicians. This means that partners no longer need to offer a comprehensive range of all categories as before. Instead, we aim to provide more personalized matching, connecting users with the most professional physicians and institutions in their specific area of interest. For instance, Meishiqin, which specializes in eye procedures, will no longer need to attract new customers by offering a wide array of services such as face-slimming injections and hyaluronic acid fillers; it can focus exclusively on its core specialty: under-eye bag treatment.

Ms. Wang Sijing, Co-founder and COO of the Gengmei App

At the conference, industry professionals from various sectors gathered to witness the unveiling of Gengmei AI and engaged in extensive discussions on the development trends and breakthrough strategies for the medical aesthetics industry in the era of new consumption. Qi Fei, Investment Director at Legend Capital, stated that in this new consumption era, the industry needs to reconstruct industrial relationships with a user-centric approach. Qi Fei offered the following recommendations to institutions: selecting platforms for precise customer acquisition can help reduce the sales expense ratio; meanwhile, institutions should control store size and optimize location selection to lower rental costs; finally, they should reserve room for increases in physicians’ income.

Ms. An Feifei, Deputy General Manager of Beijing Yestar Medical Aesthetic Hospital, a specially invited institutional representative at the conference, delivered a keynote speech titled “How Medical Aesthetic Institutions Can Soar in the New Consumption Era.” She stated that as the new consumption era arrives, institutions must first identify their strategic position before they can break through existing barriers. Key questions to address include whether challenges stem from product quality or brand identity, internal operations or external factors, process inefficiencies or failure to reach target users. Ms. An pointed out that pinpointing the core issue is a prerequisite for acquiring solutions; without identifying this critical point, problems cannot be resolved. From a branding perspective, she analyzed new models for breaking through industry bottlenecks, emphasizing that institutions should prioritize quality before building their brand. She further stressed that rather than focusing solely on traffic volume, institutions should concentrate on effective traffic, and alongside customer acquisition, equal attention should be paid to customer retention.

During the panel discussion on “Secrets for Leading Institutions to Break Through in the New Era of Aesthetics,” Liu Di, Founder and CEO of Gengmei APP; Qi Fei, Investment Director at Legend Capital; Yang Jingzhi, Co-investor of Jianli Meishiqin Group and General Manager of Beijing Meishiqin Medical Aesthetics; and Xue Hongyu, Deputy Director of the Department of Plastic Surgery at Peking University Third Hospital, discussed the characteristics of users, customer acquisition channels, and aesthetic trends in the current new medical aesthetics market. The discussion also covered major operational challenges encountered by the participants and their respective solutions. Finally, each panelist provided their predictions on the future development trends of the medical aesthetics industry.

Liu Di stated that during the 1.0, 2.0, and 3.0 eras of medical aesthetics, institutions have gained a deeper understanding of user demands through technological upgrades, and that eras 4.0 and 5.0 may follow. Liu Di highlighted the two themes of today’s conference: an awards ceremony for young physicians and the launch of Gengmei AI. Combining young talent with cutting-edge technology, Gengmei aims to become the dual engine driving the future of China’s medical aesthetics industry, ensuring that talented individuals are empowered by technology and that advanced technology serves people effectively.

Roundtable Discussion Guests (from left to right): Huang Yuanpu, Liu Di, Qi Fei, Yang Jingzhi, Xue Hongyu

Gold Medal Rankings, Authoritatively Released! For this conference, the Gengmei App invited esteemed judges—including Wu Guoping, Dean of Friendship Plastic Surgery Hospital Affiliated to Nanjing Medical University; Wan Lianzhuang, Dean of Hangzhou Yestar Medical Aesthetic Hospital; and Xue Hongyu, Deputy Director of the Department of Plastic Surgery at Peking University Third Hospital—along with other distinguished guests, to present awards to the winning institutions and physicians of the 2019 Young Physicians Competition.

It is reported that the selection process spanned two months, integrating votes from over 20 million aesthetic medicine users, six years of accumulated positive ratings for doctors and institutions, and professional evaluations by an expert panel composed of industry authorities. The final list comprises 108 gold-standard doctors and institutional representatives across nine categories.

Award Ceremony

With this, the Gengmei AI Launch Event and 2019 Young Doctors Competition Awards Ceremony, themed “New Trends, New Aesthetics, New Forces,” came to a successful conclusion. It has always been Gengmei App’s mission to identify outstanding physicians who demonstrate craftsmanship and medical ethics for the benefit of the industry and consumers, thereby enhancing decision-making efficiency and enabling safe, worry-free aesthetic transformations. We look forward to the advent of the Medical Aesthetics 3.0 era, ushered in by Gengmei AI.